|
|
|||
|
||||
OverviewWorld free of the devastation of diabetes is not only an admirable vision, but is a vital necessity. The discovery and isolation of insulin in 1921, by Banting and Best, paved the way for the development of a therapy which has saved the life of many diabetic patients. Insulin was the first protein to be sequenced in 1951, marking an important milestone in molecular biology. In 1976, insulin became the first recombinant drug - obtained using newly developed genetic engineering techniques - to be used for therapy in humans . Many proteins such as human insulin cannot be obtained from their natural sources in suitable quantities because of their low abundance or difficulty of purification by conventional methods. One solution is the production of recombinant human proteins in hetero-logous prokaryotic cell systems such as yeast mediated by suitable and powerful expression vectors. Identification of a simple eukaryotic system depend on the expression level, quality of biomolecules, safety, manipulation of genetic system and finally the cost of production Full Product DetailsAuthor: Mossawi RafidPublisher: LAP Lambert Academic Publishing Imprint: LAP Lambert Academic Publishing Dimensions: Width: 15.20cm , Height: 1.30cm , Length: 22.90cm Weight: 0.327kg ISBN: 9783659418341ISBN 10: 365941834 Pages: 220 Publication Date: 06 May 2015 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In stock We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |